Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients

Published:2010-01-14 Issue:3 Volume:24 Page:592-600
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Chan A C,Neeson P,Leeansyah E,Tainton K,Quach H,Prince H M,Godfrey D I,Ritchie D,Berzins S P

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2009279.pdf

Reference51 articles.

1. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L . NKT cells: what's in a name? Nat Rev Immunol 2004; 4: 231–237.

2. Bendelac A, Savage PB, Teyton L . The biology of NKT cells. Annu Rev Immunol 2007; 25: 297–336.

3. Godfrey DI, Kronenberg M . Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 2004; 114: 1379–1388.

4. Matsuda JL, Mallevaey T, Scott-Browne J, Gapin L . CD1d-restricted iNKT cells, the ‘Swiss-Army knife’ of the immune system. Curr Opin Immunol 2008; 20: 358–368.

5. Hammond KJ, Kronenberg M . Natural killer T cells: natural or unnatural regulators of autoimmunity? Curr Opin Immunol 2003; 15: 683–689.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy;Cancer Cell International;2023-05-08

2. Tumor and microenvironmental mechanisms of resistance to immunomodulatory drugs in multiple myeloma;Frontiers in Oncology;2022-11-09

3. Dysregulation of immune cell and cytokine signalling correlates with clinical outcomes in myelodysplastic syndrome (MDS);European Journal of Haematology;2022-02-03

4. Novel in vitro invariant natural killer T cell functional assays;Journal of Immunological Methods;2021-12

5. The Current Landscape of NKT Cell Immunotherapy and the Hills Ahead;Cancers;2021-10-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3